Cargando…

CEACAM6: A Novel Marker of Chronic Obstructive Pulmonary Disease Susceptibility?

Detalles Bibliográficos
Autores principales:	Racanelli, Alexandra C., Choi, Augustine M. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273108/ https://www.ncbi.nlm.nih.gov/pubmed/37219336 http://dx.doi.org/10.1164/rccm.202303-0610ED

Ejemplares similares

The Saga of Necroptosis in Chronic Obstructive Pulmonary Disease Continues
por: Racanelli, Alexandra C., et al.
Publicado: (2021)

Genetic Susceptibility to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: The Missing Link?
por: Polverino, Francesca
Publicado: (2023)

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
por: Blumenthal, Rosalyn D, et al.
Publicado: (2007)

HDAC6: A Neglected Player in Chronic Obstructive Pulmonary Disease?
por: Ito, Kazuhiro
Publicado: (2021)

Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease
por: Callaghan, M J, et al.
Publicado: (2007)

CEACAM1 promotes vascular aging processes
por: Kleefeldt, Florian, et al.
Publicado: (2020)

Energy expenditure as a marker of physical activity intensity in chronic obstructive pulmonary disease
por: Orme, Mark W
Publicado: (2021)

Allergy and Chronic Obstructive Pulmonary Disease
por: Jin, Jian-Min, et al.
Publicado: (2017)

T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction
por: Pinkert, Jessica, et al.
Publicado: (2021)

CEACAM6 Gene Variants in Inflammatory Bowel Disease
por: Glas, Jürgen, et al.
Publicado: (2011)

CEACAM6 gene expression in intrahepatic cholangiocarcinoma
por: Ieta, K, et al.
Publicado: (2006)

Smoking cessation and chronic obstructive pulmonary disease
por: Yoo, Kwang Ha
Publicado: (2015)

Metabolic syndrome and chronic obstructive pulmonary disease
por: Koul, Parvaiz A
Publicado: (2016)

Diaphragmatic dysfunction in chronic obstructive pulmonary disease
por: Sharma, Bharat Bhushan, et al.
Publicado: (2019)

Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019)

The Complex Beginnings of Chronic Obstructive Pulmonary Disease
por: Guerra, Stefano, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease: The Present and Future
por: Krishnan, Aditya, et al.
Publicado: (2022)

Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021)

Addressing the Use of the CAPTURE (a Chronic Obstructive Pulmonary Disease Screening Tool) in Chronic Obstructive Pulmonary Disease Treatment Decisions
por: Yawn, Barbara P., et al.
Publicado: (2023)

Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
por: Chan, C.H.F., et al.
Publicado: (2007)

Getting to the How and Why: Are Individuals with Chronic Obstructive Pulmonary Disease More Susceptible to the Health Effects of Air Pollution Exposure?
por: Sack, Coralynn S., et al.
Publicado: (2022)

CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas
por: Lee, Ok-Jun, et al.
Publicado: (2014)

Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease
por: Lee, Jin Hwa, et al.
Publicado: (2014)

CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens
por: Thomas, Jerin, et al.
Publicado: (2023)

What Affects Chronic Obstructive Pulmonary Disease in Korea?
por: Cho, Hae-Wol, et al.
Publicado: (2016)

High prevalence of chronic obstructive pulmonary disease in Korea
por: Rhee, Chin Kook
Publicado: (2016)

Drugging the Mighty Neutrophil in Chronic Obstructive Pulmonary Disease
por: Fessler, Michael B.
Publicado: (2019)

Validation of Imaging Measures in Chronic Obstructive Pulmonary Disease
por: Aaron, Carrie Pistenmaa, et al.
Publicado: (2019)

Chronic Obstructive Pulmonary Disease and Work: Is It Time to Stop?
por: Halpin, David
Publicado: (2019)

Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time
por: Calverley, Peter M. A., et al.
Publicado: (2019)

The Paradox of Obesity in Patients with Chronic Obstructive Pulmonary Disease
por: Yohannes, Abebaw Mengistu
Publicado: (2022)

The role of quantitative imaging in chronic obstructive pulmonary disease
por: Wada, Danilo Tadao
Publicado: (2022)

Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells
por: Klaile, Esther, et al.
Publicado: (2017)

Mind the Gap: Addressing Cardiovascular Disease in Chronic Obstructive Pulmonary Disease
por: Wells, J. Michael, et al.
Publicado: (2022)

The double jeopardy of chronic obstructive pulmonary disease and myocardial infarction
por: Sinha, Shashank S, et al.
Publicado: (2014)

Chronic obstructive pulmonary disease: Indian guidelines and the road ahead
por: Koul, Parvaiz A.
Publicado: (2013)

Comorbidities in Chronic Obstructive Pulmonary Disease from Assessment to Treatment
por: Clini, Enrico M., et al.
Publicado: (2014)

Identifying prognostic factors in chronic obstructive pulmonary disease patients
por: García-Sanz, María-Teresa
Publicado: (2017)

Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease
por: Feng, Han-Rong, et al.
Publicado: (2018)

On Trapped Air and Trapped Blood in Chronic Obstructive Pulmonary Disease
por: Watz, Henrik
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3pm9u2vf6jjjgdc21q9f42qta1